Domore Diagnostics

Domore Diagnostics company information, Employees & Contact Information

DoMore Diagnostics uses artificial intelligence to make personalized treatment decisions simple and accessible for all cancer patients. Its unique digital biomarkers predict patient outcomes from routine tumor tissue slides and can be seamlessly integrated into pathologists’ existing workflow. The lead product Histotype Px® Colorectal is a CE-IVDD marked outcome prediction marker for stage II and III colorectal adenocarcinoma that informs the decision of whether to provide adjuvant chemotherapy following surgical resection of the tumor. The company is based on prominent international research from leading universities and funded by top Norwegian tech investors.

Company Details

Employees
12
Founded
-
Address
Oslo, No
Industry
Hospitals And Health Care
NAICS
Health Care and Social Assistance
Social Assistance
HQ
Oslo
Looking for a particular Domore Diagnostics employee's phone or email?

Domore Diagnostics Questions

News

PathAI Announces Integrations with Leading AI-pathology Companies Deep Bio, DoMore Diagnostics, Paige, and Visiopharm, through its AISight Image Management System - Yahoo Finance

PathAI Announces Integrations with Leading AI-pathology Companies Deep Bio, DoMore Diagnostics, Paige, and Visiopharm, through its AISight Image Management System Yahoo Finance

Digital Health in Oncology – Emerging Opportunities Across the Cancer Patient Journey - MedCity News

Digital Health in Oncology – Emerging Opportunities Across the Cancer Patient Journey MedCity News

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant